← Eichor
Study identifier: NCT06688760 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma

Condition: Nasopharyngeal Carcinoma · Surgery · Radiotherapy  ·  Sponsor: Ming-Yuan Chen

PhaseNA
Planned participants86
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to compare the efficacy and safety of endoscopic nasopharyngectomy combined with retropharyngeal lymph nodes dissection plus bilateral upper neck lymph node dissection or plus postoperative low-dose radiotherapy in newly diagnosed stage Ⅰ nasopharyngeal carcinoma.

This description comes directly from the study's public registry record.

Talk to the study team

Ming-Yuan Chen, MD,PhD  ·  +8613903052650  ·  chmingy@email.sysu.edu.cn

You-Ping Liu, PhD  ·  +8613751763276  ·  liuyp78@email.sysu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (2)

The Fifth Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, Guangdong, ChinaRecruiting
The Fifth Affiliated Hospital of Sun Yat-sen UniversityZhuhai, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06688760